OVERVIEW OF PRIMARY ENDPOINTS, PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) FOR NON-SMALL CELL LUNG CANCER (NSCLC): THEIR VALUE IN TREATMENT DECISIONS AND PATIENT CARE

被引：0
|
作者：
Heron, Louise [1 ]
Chouaid, Christos [2 ]
Vergnenegre, Alain
Bischoff, Helge [3 ]
Walzer, Stefan [4 ]
机构：
[1] Mapi Values, Value Sight & Commun, Boston, MA USA
[2] Hop St Antoine, Lille, France
[3] Univ Heidelberg, Thoraxklin, D-6900 Heidelberg, Germany
[4] F Hoffmann La Roche Pharmaceut AG, Basel, Switzerland
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Progression; survival; endpoints;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1447 / S1448
页数：2
相关论文
共 50 条
  • [1] OVERVIEW OF PRIMARY ENDPOINTS, PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) FOR NON-SMALL CELL LUNG CANCER (NSCLC): THEIR VALUE IN TREATMENT DECISIONS AND PATIENT CARE
    Heron, L.
    De Castro Carpeno, J.
    Chouaid, C.
    Vergnenegre, A.
    Bischoff, H. G.
    Walzer, S.
    VALUE IN HEALTH, 2011, 14 (03) : A177 - A178
  • [2] Progression-free survival (PFS) and overall survival (OS) in phase HI trials of systemic chemotherapy in advanced non-small cell lung cancer (NSCLC).
    Hotta, K.
    Kiura, K.
    Takigawa, N.
    Tabata, M.
    Fujiwara, Y.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] VALUE OF PROGRESSION-FREE SURVIVAL (PFS) IN REFRACTORY NON-SMALL CELL LUNG CANCER (NSCLC): AN EXPLORATORY MODELING ANALYSIS
    Ferrufino, C. P.
    Foley, D.
    Trochlil, K.
    Munakata, J.
    VALUE IN HEALTH, 2011, 14 (07) : A447 - A447
  • [4] Time trends in overall survival (OS) and progression-free survival (PFS) in the first-line treatment of advanced non-small-cell lung cancer (NSCLC).
    Rutkowski, Jacek
    Saad, Everardo D.
    Buyse, Marc E.
    Jassem, Jacek
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] THE OVERALL SURVIVAL (OS) AND PROGRESSION-FREE SURVIVAL (PFS) OF HYPERPROGRESSIVE DISEASE (HDP) IN LUNG CANCER PATIENTS
    Oh, Youjin
    Djunadi, Trie Arni
    Chung, Liam Il-Young
    Lee, Soowon
    Hong, Timothy
    Shah, Zunairah
    Park, Joo Hee
    Yoon, Sung Mi
    Duan, Richard
    Chae, Young Kwang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1468 - A1469
  • [6] LONG-TERM EXTRAPOLATION OF OVERALL SURVIVAL (OS) AND PROGRESSION-FREE SURVIVAL (PFS) FOR THE LUNAR TRIAL IN METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) FOLLOWING PROGRESSION ON PLATINUM-BASED THERAPY
    Wang, B.
    Wu, E.
    Nino, de Rivera Guzman J.
    VALUE IN HEALTH, 2024, 27 (12)
  • [7] Insulin-like growth factor binding proteins related to progression-free survival (PFS) and overall survival (OS) in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy
    Karmali, R.
    Fidler, M. J.
    Cela, I.
    Olmsted, G.
    Rouhi, O.
    Basu, S.
    Walters, K. K.
    Coon, J.
    Bonomi, P.
    Borgia, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Influence of crossover therapy on the association between progression-free survival (PFS) and overall survival (OS) in randomized trials of molecular-targeted agents for advanced non-small cell lung cancer (NSCLC).
    Hotta, K.
    Kiura, K.
    Suzuki, E.
    Takigawa, N.
    Fujiwara, Y.
    Ichihara, E.
    Tabata, M.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Progression-Free Survival (PFS) as a Surrogate for Overall Survival (OS) in Advanced Non-Small Cell Lung Cancer (aNSCLC): Analysis of Patient-Level Pooled Randomized Clinical Trials (RCTs)
    Ports, Kayleen
    Chen, Weixi
    Aptekar, Jacob
    Jain, Rahul
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 178 - 178
  • [10] Superior overall survival (OS), progression-free survival (PFS), and clinical response (CR) predictions for patients with non-small cell lung cancer (NSCLC) using Cellworks Singula: myCare-022-05.
    Velcheti, Vamsidhar
    Castro, Michael
    Watson, Drew
    Kapoor, Shweta
    Tyagi, Anuj
    Sauban, Mohammed
    Alam, Aftab
    Roy, Kunal Ghosh
    Rajagopalan, Swaminathan
    Kulkarni, Shruthi
    Mundkur, Nirjhar
    Christie, Jim
    Suseela, Rakhi Purushothaman
    Ghosh, Adity
    Basu, Kabya
    Sahu, Diwyanshu
    Ullal, Yashaswini
    Nair, Prashant
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345